Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.

Recruiting now

Conditions studied: Acute Myeloid Leukemia

In brief

The white blood cells of patients with acute myeloid leukemia that have undergone allogeneic stem cell transplantation will be investigated. These are patient where the leukemia has returned after the transplantation.

Key facts

Study ID

NCT07627568

Run by

University of Freiburg

People needed

20

Starts

2026-05-30

Expected to finish

2027-05-30

Last updated by the study team

2026-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of acute myeloid leukemia with NPM1 mutations or KMT2A rearrangements
• Hematological relapse after allo-HCT
• 18 years or older

You may not qualify if…

• no signed informed consent

Where it is running

• University of Freiburg Mdical Center — Freiburg im Breisgau, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.